• 

  The prognostic role of circulating tumor cells (CTCs) in lung cancer 

  O'Byrne, Ken (2018)
• 

  Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials 

  O'Byrne, Ken (2018)
• 

  Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: Achieving the full therapeutic potential of HDACi 

  O'Byrne, Ken (2018)
• 

  Phenolic Glycolipid Facilitates Mycobacterial Escape from Microbicidal Tissue-Resident Macrophages. 

  KEANE, JOSEPH; O'SULLIVAN, MARY (2017)
• 

  VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics 

  HARDIMAN, ORLA (2018)

View more